The Alberta government will cover the estimated $18,500 per month cost of the trademark drug, Albrioza. The province added Albrioza to the Alberta Drug Benefit List on Aug. 1, allowing eligible patients to be reimbursed for the treatment. The Addition of Albrioza to the Alberta Drug Benefit ListThe addition of Albrioza to the Alberta Drug Benefit List means that the drug is now covered by public funding. – The Alberta government will cover the cost of the ALS drug, Albrioza, for eligible patients. – Patients can be eligible for coverage through Alberta Blue Cross if they meet certain criteria and receive a prescription from a neurologist.
